PA5-55072
antibody from Invitrogen Antibodies
Targeting: LURAP1L
bA3L8.2, C9orf150, FLJ38505, LRAP35b, MGC46502
Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Immunocytochemistry [2]
- Immunohistochemistry [1]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-55072 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- LURAP1L Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Recombinant protein fragment
- Description
- Immunogen sequence: KVPESLVRSL RGEEPVPRER DRDPCGGSGG GGGGGGGCSS SSSYCSFPPS LSSSSSSSPT SGSPRGSHSS ALERLETKLH LLRQEMVNLR ATDVRLMRQL LVINESIESI KW Highest antigen sequence identity to the following orthologs: Mouse - 78%, Rat - 79%.
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µL
- Concentration
- 0.1 mg/mL
- Storage
- Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Submitted references PDGF-BB regulates the transformation of fibroblasts into cancer-associated fibroblasts via the lncRNA LURAP1L-AS1/LURAP1L/IKK/IκB/NF-κB signaling pathway.
Ren X, Li L, Wu J, Lin K, He Y, Bian L
Oncology letters 2021 Jul;22(1):537
Oncology letters 2021 Jul;22(1):537
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescent staining of LURAP1L in human cell line A-431 shows positivity in nucleoli. Samples were probed using a LURAP1L Polyclonal Antibody (Product # PA5-55072).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorecent analysis of LURAP1L in human cell line A-431 using LURAP1L Polyclonal Antibody (Product # PA5-55072). Staining shows localization to nucleoli.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of LURAP1L in human testis using LURAP1L Polyclonal Antibody (Product # PA5-55072) shows strong cytoplasmic positivity in cells of seminiferus ducts.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 2. Result of the target gene prediction and dual-luciferase reporter assay. The cells were treated with 30 ng/ml PDGF-BB in 10% fetal bovine serum for 72 h for three passages. (A) Reverse transcription-quantitative PCR analysis was performed to evaluate the expression of LURAP1L. Data are presented as the mean +- SEM of triplicate experiments. (B) Western blot analysis of LURAP1L. Densitometry was used to determine the LURAP1L/beta-actin ratios. Data are presented as means +- SEM of three independent experiments. (C) Dual-luciferase reporter assay was performed to verify the regulatory effect of LURAP1L-AS1 on LURAP1L. *P